Activity and Heterogeneity of Astrocytes in Neurological Diseases: Molecular Mechanisms and Therapeutic Targets
MedComm · 2025-09 · 6 (9)
DOI: 10.1002/mco2.70329 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 22.08.2025. Verfasst von Shijie Mao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology School of Medicine Jiangsu Provincial Key Laboratory of Critical Care Medicine Southeast University Nanjing China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 265 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Astrocytes, the most prevalent glial cells in the central nervous system (CNS), play crucial roles in maintaining CNS homeostasis and responding to various pathological stimuli. They play key roles in neural development, neurotransmission, neuroinflammation, metabolic support, and tissue repair. Recent advancements in single‐cell sequencing have revealed the remarkable heterogeneity of astrocytes, with distinct subpopulations differentially contributing to disease progression in neurological disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, ischemic stroke, intracerebral hemorrhage, and multiple sclerosis. In addition, they play an important role in various behavioral neuropsychiatric disorders. This review highlights the dual roles of astrocytes in disease progression, driven by their diverse molecular profiles and functions. It outlines the key molecular mechanisms underlying astrocyte heterogeneity and their impact on neuroinflammation, neuronal support, and ionic balance regulation. Additionally, the review discusses potential therapeutic strategies targeting astrocytes to modulate these processes, aiming to improve treatment outcomes in neurological diseases. By elucidating the specific roles of astrocyte subsets in disease, this review seeks to advance the development of precision medicine for astrocyte‐related neurological disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology School of Medicine Jiangsu Provincial Key Laboratory of Critical Care Medicine Southeast University Nanjing China.
- State Key Laboratory of Oncology in South China Guangdong Provincial Clinical Research Center for Cancer Sun Yat-sen University Cancer Center Guangzhou China.
- Department of Radiology Center of Interventional Radiology and Vascular Surgery Zhongda Hospital Medical School Southeast University Nanjing China.
ORCID-Profile: Ying Bai
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Mao, S., Qiao, R., Wang, Q., Shen, L., Li, D., Huo, X., Wang, J., Liu, K., Chen, W., Zhu, T., Zhang, B., Leng, S., & Bai, Y. (2025). Activity and Heterogeneity of Astrocytes in Neurological Diseases: Molecular Mechanisms and Therapeutic Targets. MedComm, 6(9). https://doi.org/10.1002/mco2.70329
Vancouver
Mao S, Qiao R, Wang Q, Shen L, Li D, Huo X, et al. Activity and Heterogeneity of Astrocytes in Neurological Diseases: Molecular Mechanisms and Therapeutic Targets. MedComm. 2025;6(9). doi:10.1002/mco2.70329
BibTeX
@article{Mao2025,
author = {Mao, Shijie and Qiao, Rui and Wang, Qi and Shen, Ling and Li, Daxing and Huo, Xinchen and Wang, Jindou and Liu, Kunxuan and Chen, Wenjing and Zhu, Tianhao and Zhang, Beicheng and Leng, Shuo and Bai, Ying},
title = {Activity and Heterogeneity of Astrocytes in Neurological Diseases: Molecular Mechanisms and Therapeutic Targets},
journal = {MedComm},
year = {2025},
volume = {6},
number = {9},
doi = {10.1002/mco2.70329}
}
EUVIMED